With the emergence of antibody-drug conjugates, the genitourinary cancers space is rapidly evolving. Robert L. Ferris, MD, ...
In this segment focused on advanced renal cell carcinoma, Dr. Geynisman shifts the discussion to patients with intermediate ...
New analysis of 2304 patients shows CD19 CAR T-cell therapy efficacy is consistent across races, with outcomes driven by ...
Dr. Costa emphasizes that absence of prior BCMA-directed therapy and treatment history represent fundamental elements guiding ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results